UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030078 |
|---|---|
| Receipt number | R000034339 |
| Scientific Title | Palliative care research as a whole person approach in comprehensive medical care internal medicine |
| Date of disclosure of the study information | 2017/11/22 |
| Last modified on | 2020/02/21 20:53:26 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Palliative care research as a whole person approach in comprehensive medical care internal medicine
Acronym
Palliative care by comprehensive internal medicine
Scientific Title
Palliative care research as a whole person approach in comprehensive medical care internal medicine
Scientific Title:Acronym
Palliative care by comprehensive internal medicine
Region
| Japan |
Condition
Condition
General medical disorder at the terminal stage
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Cardiology | Pneumology | Hematology and clinical oncology |
| Geriatrics | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Symptomatic relief and mental stability
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Symptom control score
Evaluation every 2 weeks
Key secondary outcomes
Questionnaire survey on spiritual stability of the person and family
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Consent from the patient or family
Key exclusion criteria
Did not obtain consent
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Toru |
| Middle name | |
| Last name | Noguchi |
Organization
saitama medical university
Division name
Department of General Internal Medicine
Zip code
350-0495
Address
38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan
TEL
049-276-1667
guchan@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | Toru |
| Middle name | |
| Last name | Noguchi |
Organization
Saitama Medical University
Division name
Department of General Internal Medicine
Zip code
350-0495
Address
38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan
TEL
049-276-1111
Homepage URL
guchan@saitama-med.ac.jp
Sponsor or person
Institute
Saitama Medical University
Department of General Internal Medicine
Institute
Department
Personal name
Funding Source
Organization
Saitama Medical University
Department of General Internal Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board in Saitama medical university hospital
Address
38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan
Tel
049-276-1354
049-276-1354
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
埼玉医科大学病院（埼玉県）
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 11 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 12 | Month | 04 | Day |
Date of IRB
| 2017 | Year | 12 | Month | 04 | Day |
Anticipated trial start date
| 2017 | Year | 12 | Month | 04 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2019 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2019 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2019 | Year | 04 | Month | 30 | Day |
Other
Other related information
Patient satisfaction is high due to intervention of palliative care team on symptom control of terminal chronic disease.
Management information
Registered date
| 2017 | Year | 11 | Month | 22 | Day |
Last modified on
| 2020 | Year | 02 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034339
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
